DOMK, PPHM, MDHI & Extended Watchlist

DoMark International, Inc. DOMK

Typically our sweet spot for stocks are in the low price range between subpenny and .25, however every once in awhile, we do come across a big-gaining stock in a higher price range. This was the case with DOMK when we discussed it back on April 12th. We saw it catapult from 3.44 to 4.88, making gains up to 42%. We then followed as it dipped to 1.67, only to bounce as high as 3.63, for an added run of 131%

After that run, the stock slid into a downtrend, and we monitored from the sidelines as it reached a low of .32 in the month of August. Last Wednesday, the stock jumped once again from .325 to .765 for a huge 135% rip. It then consolidated to find a higher level of support in the low .50’s, and yesterday we saw a close at the high of day, up 23% at .67.

The company is anticipating the release of the iPhone 5, for reasons outlined in yesterday’s PR:

LONGWOOD, FLORIDA, Sep 05, 2012 (MARKETWIRE via COMTEX) — This document corrects and replaces the press release that was sent today at 8:35 am ET.

DoMark International Inc. (OTCBB: DOMK) (the “Company” or “DoMark”), through its wholly owned subsidiary, SolaWerks Inc., is moving forward with several product developments in anticipation of the release of the iPhone 5 by Apple. The iPhone 5 is potentially the most anticipated mobile device release in history. Apple is expected to announce the release of the iPhone 5 in San Francisco at 10:00 am EST on September 12, 2012. Sales are expected to commence September 21.

DoMark is actively preparing for the iPhone 5 release, which has high potential to be Apple’s strongest product launch in history. DoMark is presently seeking to replenish its stock of SolaPads and SolaCases. Furthermore, as the iPhone 5 specifications become available, DoMark will launch reconfigured versions of its best selling SolaPad and SolaCase for the new device as with all upcoming Apple mobile devices.


Peregrine Pharmaceuticals, Inc. PPHM

We first began talking about PPHM on August 14th. Following that first alert the stock ran from 2.30 to 3.09. As we watched it consolidate, we were sure to keep it in our extended watchlist. On August 27th it appeared there, as we observed a new low of 1.76. Yesterday, we saw the stock reach a new high of 3.21, marking a gain of 82% for anyone sharp enough to time that bottom.

Between this play and the above mentioned one, it becomes clear that we can in fact have good fortune with relatively high-priced stocks.


Medical Alarm Concepts Holding, Inc. MDHI

For those who still prefer the pennies, we re-submit MDHI. Back on August 6th, we first talked about this play, being as low as .003. In just a couple days, it hit .0046, then in another few weeks, we saw highs of .005.

For the past three trading sessions, the stock has been holding higher lows and making higher highs, which landed it back on our watch screens. There is a golden cross formation setting up on the chart with the 20DMA (.0041) preparing to breach the 100DMA (.0042). There is a key level resistance at the 200DMA of .0053. Other bullish points to take in from the annotated chart we’ve linked to below, the Accum./Dist. has been steadily increasing since the end of July, and the RSI appears to be strengthening. The Slow STO has also recently crossed over.

Here is a link to an annotated chart on MDHI.

In addition, news out this morning could give MDHI the push it needs to negotiate its way through its key resistance:

KING OF PRUSSIA, Pa., Sept. 6, 2012 /PRNewswire via COMTEX/ — Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK), manufacturer of the MediPendant(TM) two-way voice personal medical alarm, today announces the retirement of the last portion of it outstanding Series B Convertible Preferred shares.

Ronald Adams CEO commented, “Over the past few months we have negotiated the cancellation of a large portion of convertible debt, the cancellation of 165 million toxic warrants most of which were in the money, and now the final piece of Series B Convertible Preferred shares. All of our Series A preferred had been retired previously. As we prepare to move into profitability and back into fully reporting status, these retirements and cancellations will allow us to reflect the true worth of our business on upcoming balance sheets and in our other financials.”


Extended Watchlist: